Seven years’ follow-up of comparative study between stenting and medication for treatment of symptomatic vertebrobasilar artery stenosis

Abstract

Objective

Endovascular stent-assistant angioplasty (ESAA) is a valid treatment for symptomatic vertebrobasilar artery stenosis (SVAS), but the long-term effect and the improvement of condition compared with medication treatment are unknown. This study investigated the long-term efficacy of ESAA in patients with moderate and severe SVAS, and compared the efficacy with medication treatment.

Materials and methods

We conducted a retrospective analysis of clinical data of 43 patients with moderate and severe SVAS hospitalized in our department. According to different treatment methods they were divided into 29 cases in an ESAA group and 14 cases in a medication treatment group. During the follow-up period, the degree of vascular stenosis, vascular blood flow velocity, restenosis rate, recovery of neurological function and the incidence of cerebral ischemic events in the two groups were analyzed.

Results

The average clinical follow-up period was 89.4 ± 10.2 months. Before treatment, the stenosis rate and average blood flow velocity of the two groups were not statistically significant (p > 0.05). During the follow-up period, both were significantly lower than the medication treatment group (p < 0.01). In the ESAA group, three cases of stent stenosis, and three cases in the medication treatment group were completely occluded. The total ischemic events in ESAA group were three cases, compared with nine cases in the medication treatment group; the difference was statistically significant (p < 0.05).

Conclusion

ESAA has a long-term effect in the treatment of symptomatic moderate and severe vertebrobasilar artery stenosis. It is superior to medication therapy in preventing posterior circulation ischemia (PCI), but a larger sample size is still needed to confirm the study.

Keywords

Endovascular stent angioplasty stenosis vertebrobasilar artery medication

Get full access to this article

View all access options for this article.

References

Wang

Cui

et al.

The China National Stroke Registry for patients with acute cerebrovascular events: Design, rationale, and baseline patient characteristics. Int J Stroke 2011; 6: 355–361.

Benjamin

Blaha

Chiuve

et al.

Heart Disease and Stroke Statistics—2017 Update: A report from the American Heart Association. Circulation 2017; 135: e146–e603.

Carrera

Maeder-Ingvar

Rossetti

et al.

Trends in risk factors, patterns and causes in hospitalized strokes over 25 years: The Lausanne Stroke Registry. Cerebrovasc Dis 2007; 24: 97–103.

Marquardt

Kuker

Chandratheva

et al.

Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: Prospective population-based study. Brain 2009; 132(Pt 4): 982–988.

Gulli

Khan

Markus

. Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke 2009; 40: 2732–2737.

Weber

Kraywinkel

Diener

et al.

Symptomatic intracranial atherosclerotic stenoses: Prevalence and prognosis in patients with acute cerebral ischemia. Cerebrovasc Dis 2010; 30: 188–193.

Yan

Liang

Chen

et al.

Treatment of symptomatic vertebrobasilar artery stenosis with stent-assistant angioplasty in the elderly. Rev Assoc Med Bras (1992) 2012; 58: 422–426.

Edgell

Zaidat

Gupta

et al.

Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis: Results from the Society of Vascular and Interventional Neurology Research Consortium. J Neuroimaging 2013; 23: 170–174.

Mohammadian

Sharifipour

Mansourizadeh

et al.

Angioplasty and stenting of symptomatic vertebral artery stenosis clinical and angiographic follow-up of 206 cases from Northwest Iran. Neuroradiol J 2013; 26: 454–463.

10.

Kim

Lee

Choi

et al.

Long-term outcome of vertebral artery origin stenosis in patients with acute ischemic stroke. BMC Neurol 2013; 13: 171.

11.

SSALVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study results. Stroke 2004; 35: 1388–1392.

12.

Chimowitz

Lynn

Turan

et al.

Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis 2011; 20: 357–368.

13.

North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–453.

14.

Kocak

Korkmazer

Islak

et al.

Endovascular treatment of extracranial vertebral artery stenosis. World J Radiol 2012; 4: 391–400.

15.

Tsuura

Terada

Masuo

et al.

Clinical results of percutaneous transluminal angioplasty and stenting for intracranial vertebrobasilar atherosclerotic stenoses and occlusions. Interv Neuroradiol 2004; 10(Suppl 2): 21–25.

16.

Spilker

Kongable

Barch

et al.

Using the NIH Stroke Scale to assess stroke patients. The NINDS rt-PA Stroke Study Group. J Neurosci Nurs 1997; 29: 384–392.

17.

Malek

Higashida

Phatouros

et al.

Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 1999; 30: 2073–2085.

18.

Taylor

Siddiq

Suri

et al.

Risk factors for in-stent restenosis after vertebral ostium stenting. J Endovasc Ther 2008; 15: 203–212.

19.

Nouh

Remke

Ruland

. Ischemic posterior circulation stroke: A review of anatomy, clinical presentations, diagnosis, and current management. Front Neurol 2014; 5: 1–16.

20.

Gulli

Marquardt

Rothwell

et al.

Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis pooled data analysis from prospective studies. Stroke 2013; 44: 598–604.

21.

Ota

Usami

Iijima

et al.

Staged surgical treatment for symptomatic vertebrobasilar artery stenosis: Combined treatment with endovascular angioplasty and bypass surgery. World Neurosurg 2012; 78: 90–94.

22.

Ramirez

Febrer

Gaudric

et al.

Open repair of vertebral artery: A 7-year single-center report. Ann Vas Surg 2012; 26: 79–85.

23.

Lee

Morasch

. Treatment of vertebral disease: Appropriate use of open and endovascular techniques. Semin Vasc Surg 2011; 24: 24–30.

24.

Chimowitz

Lynn

Derdeyn

et al.

Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365: 993–1003.

25.

Tang

Chang

Chern

et al.

Stenting versus medical treatment for severe symptomatic intracranial stenosis. Am J Neuroradiol 2011; 32: 911–916.

26.

Zhao

Barlinn

Sharma

et al.

Velocity criteria for intracranial stenosis revisited: An international multicenter study of transcranial Doppler and digital subtraction angiography. Stroke 2011; 42: 3429–3434.

27.

Felberg

Christou

Demchuk

et al.

Screening for intracranial stenosis with transcranial Doppler: The accuracy of mean flow velocity thresholds. J Neuroimaging 2002; 12: 9–14.

28.

Ghorbani

Ashtari

Fatehi

. The assessment value of transcranial Doppler sonography versus magnetic resonance angiography in vertebrobasilar stroke. J Res Med Sci 2010; 15: 133–139.

29.

Younis

Gupta

Mortazavi

et al.

Predictors of carotid stent restenosis. Catheter Cardiovasc Interv 2007; 69: 673–682.

30.

Fiorella

Chow

Anderson

et al.

A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007; 61: 236–243.

31.

Martin-Schild

Albright

Tanksley

et al.

Zero on the NIHSS does not equal the absence of stroke. Ann Emerg Med 2011; 57: 42–45.